Health · 1 views

Milestone Pharmaceuticals Inc .: Milestone Pharmaceuticals Announces U . S . Availability of CARDAMYST ( etripamil ) Nasal Spray , the First and Only FDA - Approved Self - Administered Treatment for Adults with Paroxysmal Supraventricular Tachycardia...

CARDAMYST is now conveniently available to patients through retail pharmaciesNational sales force hired with promotional launch in mid-Fe…

Source finanznachrichten.de AI Summary Updated January 26, 2026

Story intelligence Beta

Freshness Stale Updated January 26, 2026

Confidence Limited Single-outlet story

Coverage Single outlet

Views 1 Community interest

Read time 1 min ~25 words

AI Summary

CARDAMYST is now conveniently available to patients through retail pharmaciesNational sales force hired with promotional launch in mid-FebruaryExpected $25 copay cap for eligible commercially insured

Read full article on Finanznachrichten

AI summaries can be wrong sometimes—always verify important details using the source article.